Insurance · Founded 1972 · www.gicre.in · BSE 540755 · NSE GICRE · ISIN INE481Y01014
No Notes Added Yet
Business
General Insurance Corporation of India (GICRE) is India's largest domestic reinsurance company, often referred to as the "National Reinsurer." Its core business is to provide reinsurance coverage to other insurance companies, absorbing a portion of their risks in exchange for a premium. This helps primary insurers manage their capital, diversify risk, and increase their underwriting capacity. GICRE underwrites various classes of non-life insurance business (like property, marine, aviation, motor, health, agriculture, liability) both in India and internationally. It makes money primarily through underwriting profits (premiums minus claims and operating expenses) and investment income generated from its substantial premium float.
Revenue Mix
GICRE operates as a diversified general reinsurer. While specific revenue mixes can fluctuate, its major lines of business typically include:
Property Reinsurance: Covering industrial and commercial properties against fire, natural catastrophes, and other perils.
Marine & Aviation Reinsurance: Covering cargo, hull, and aviation-related risks.
Motor & Health Reinsurance: Supporting primary insurers in these large retail segments.
Agriculture & Crop Reinsurance: A significant segment in India given the importance of the agricultural sector.
Liability & Miscellaneous Reinsurance: Covering a range of other risks including professional indemnity, engineering, and personal accident.
International Business: A substantial portion of its business is derived from international markets, where it reinsures risks for insurers in other countries.
Industry
The Indian reinsurance industry was historically a near-monopoly for GICRE until market liberalization. Currently, GICRE operates in a competitive landscape with several foreign reinsurers (e.g., Swiss Re, Munich Re, Hannover Re, Scor) having established branches in India. Despite increased competition, GICRE remains the largest domestic reinsurer. Its positioning is bolstered by its long-standing relationships with Indian primary insurers and a mandatory cession regime where primary general insurers in India are required to cede a certain percentage (currently 5%) of their risks to GICRE, subject to certain conditions.
MOAT
GICRE benefits from several durable advantages:
Regulatory Backing (Mandatory Cession): Indian general insurers are required to cede a portion of their reinsurance business to GICRE, providing a stable, captive revenue stream. This is a significant regulatory moat.
Scale and Capital: As one of the largest reinsurers globally and the dominant player in India, GICRE possesses a substantial capital base, enabling it to underwrite large and complex risks that smaller players cannot.
Deep Relationships: Decades of operation have built strong relationships and trust with primary insurers in India.
Underwriting Expertise: Extensive experience in understanding and pricing Indian-specific risks, including catastrophe models and agricultural risks.
Growth Drivers
Growth in Indian Primary Insurance Market: Economic growth, rising disposable incomes, increasing insurance awareness, and product innovation will drive higher penetration of primary insurance, leading to greater demand for reinsurance.
Infrastructure Development: Large-scale infrastructure projects in India create a demand for substantial property and liability insurance, and consequently, reinsurance.
Catastrophe Risk Awareness: Increased frequency and severity of natural catastrophes drive demand for robust reinsurance coverage from primary insurers.
International Expansion: Continued focus on growing its international book of business diversifies its risk portfolio and revenue streams.
Regulatory Support: While subject to change, the mandatory cession currently provides a baseline for growth.
Risks
Catastrophe Losses: Exposure to large-scale natural disasters (earthquakes, floods, cyclones) in India and globally can lead to significant claim payouts, impacting profitability.
Underwriting Cycle Volatility: The reinsurance market is cyclical, with periods of soft (lower premiums, looser terms) and hard (higher premiums, tighter terms) markets, affecting underwriting profitability.
Investment Market Volatility: A significant portion of its income comes from investments. Fluctuations in equity, debt, and real estate markets can impact investment income and balance sheet.
Increased Competition: Liberalization of the Indian reinsurance market has brought in global players, intensifying competition and potentially pressuring premium rates.
Regulatory Changes: Any adverse changes to the mandatory cession requirement or other insurance regulations could negatively impact GICRE's business model.
Climate Change: Long-term impact of climate change on weather patterns could lead to higher claims, particularly in property and agricultural lines.
Management & Ownership
GICRE is a Public Sector Undertaking (PSU) with the Government of India as its promoter and majority shareholder. This implies a degree of government oversight and strategic direction. The management team consists of seasoned professionals within the insurance and reinsurance sector, appointed through government processes. The government's majority ownership provides stability but can also lead to decisions influenced by broader national policy objectives rather than purely commercial motives.
Outlook
GICRE faces a dual outlook. On one hand, it stands to benefit significantly from the robust growth trajectory of the Indian primary insurance market, driven by favorable demographics, economic expansion, and increasing awareness. Its established position as the national reinsurer, coupled with the mandatory cession, provides a stable base and a competitive edge against other market participants. Diversification into international markets further enhances its revenue potential and risk management capabilities. However, GICRE operates in an inherently risky business. It is exposed to large-scale catastrophe events, volatility in global investment markets, and intense competition from well-capitalized global reinsurers. Any adverse changes in regulatory policies, particularly concerning mandatory cessions, or a significant downturn in underwriting cycles could put pressure on its profitability and market share. Its performance will largely depend on its ability to effectively manage underwriting risks, optimize its investment portfolio, and navigate the evolving competitive landscape while leveraging its strategic advantages.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 7274 | 10098 | 8886 | 8478 | 9250 | 11274 | 8925 | 9631 | 9914 | 11098 |
| Other Income | 3098 | 2823 | 3398 | 2921 | 4104 | 3408 | 4383 | 3093 | 3750 | 3474 |
| Total Income | 10372 | 12921 | 12285 | 11399 | 13354 | 14682 | 13308 | 12723 | 13663 | 14572 |
| Total Expenditure | 7276 | 11431 | 9998 | 9215 | 10210 | 12018 | 9993 | 10363 | 10556 | 12380 |
| Operating Profit | 3096 | 1490 | 2287 | 2184 | 3144 | 2664 | 3315 | 2360 | 3108 | 2192 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3096 | 1490 | 2287 | 2184 | 3144 | 2664 | 3315 | 2360 | 3108 | 2192 |
| Provision for Tax | 542 | 368 | 422 | 560 | 780 | 491 | 617 | 609 | 729 | 571 |
| Profit After Tax | 2554 | 1122 | 1865 | 1623 | 2364 | 2173 | 2698 | 1751 | 2378 | 1621 |
| Adjustments | 26 | 279 | -9 | 53 | 135 | 358 | 176 | -26 | 154 | 123 |
| Profit After Adjustments | 2580 | 1401 | 1856 | 1677 | 2499 | 2531 | 2874 | 1726 | 2533 | 1744 |
| Adjusted Earnings Per Share | 14.7 | 8 | 10.6 | 9.6 | 14.2 | 14.4 | 16.4 | 9.8 | 14.4 | 9.9 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 15300 | 26776 | 38200 | 38250 | 44351 | 39985 | 39557 | 35974 | 33705 | 36712 | 39743 | 39568 |
| Other Income | 2964 | 3022 | 3986 | 4873 | 5994 | 6599 | 7780 | 8137 | 8796 | 8877 | 9580 | 14700 |
| Total Income | 18264 | 29798 | 42186 | 43123 | 50345 | 46584 | 47337 | 44110 | 42500 | 45589 | 49324 | 54266 |
| Total Expenditure | 16607 | 27198 | 39668 | 40364 | 51124 | 45296 | 44146 | 38774 | 37814 | 39996 | 41895 | 43292 |
| Operating Profit | 1658 | 2600 | 2518 | 2759 | -780 | 1288 | 3191 | 5337 | 4687 | 5593 | 7429 | 10975 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3125 | 4168 | 3580 | 3973 | -274 | 3236 | 3942 | 8361 | 8103 | 9563 | 12109 | 10975 |
| Provision for Tax | 108 | 496 | 435 | 1216 | -87 | 1244 | 1556 | 1454 | 1417 | 2131 | 2446 | 2526 |
| Profit After Tax | 3017 | 3672 | 3146 | 2758 | -186 | 1992 | 2386 | 6907 | 6686 | 7432 | 9662 | 8448 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 427 |
| Profit After Adjustments | 3017 | 3672 | 3146 | 2758 | -186 | 1992 | 2386 | 6907 | 6686 | 7432 | 9662 | 8877 |
| Adjusted Earnings Per Share | 17.5 | 106.7 | 17.9 | 15.7 | -1.1 | 11.4 | 13.6 | 39.4 | 38.1 | 42.4 | 55.1 | 50.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 8% | 3% | -0% | 10% |
| Operating Profit CAGR | 33% | 12% | 42% | 16% |
| PAT CAGR | 30% | 12% | 37% | 12% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -12% | 13% | 18% | NA% |
| ROE Average | 18% | 17% | 16% | 14% |
| ROCE Average | 22% | 21% | 21% | 17% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 17058 | 20183 | 24155 | 25492 | 23944 | 26253 | 28827 | 35996 | 41935 | 48659 | 59296 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 36053 | 45975 | 45567 | 48513 | 36312 | 52028 | 56246 | 57643 | 70797 | 70707 | 66892 |
| Total Current Liabilities | 30620 | 33804 | 46054 | 52111 | 64331 | 66357 | 71652 | 75894 | 80572 | 86233 | 92714 |
| Total Liabilities | 83730 | 99961 | 115775 | 126116 | 124587 | 144638 | 156724 | 169533 | 193304 | 205599 | 218903 |
| Fixed Assets | 198 | 192 | 200 | 225 | 209 | 200 | 200 | 324 | 318 | 319 | 320 |
| Other Non-Current Assets | 56052 | 66820 | 74091 | 82306 | 71173 | 94222 | 104906 | 115513 | 136603 | 144117 | 149549 |
| Total Current Assets | 27480 | 32950 | 41485 | 43586 | 53204 | 50216 | 51618 | 53696 | 56383 | 61163 | 69034 |
| Total Assets | 83730 | 99961 | 115775 | 126116 | 124587 | 144638 | 156724 | 169533 | 193304 | 205599 | 218903 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 7749 | 9779 | 12231 | 14257 | 12933 | 16107 | 18589 | 21451 | 7495 | 7770 | 7717 |
| Cash Flow from Operating Activities | 5876 | 7901 | 8837 | 7604 | 8617 | 13284 | 9051 | 11722 | -212 | 1976 | 466 |
| Cash Flow from Investing Activities | -4534 | -4354 | -5502 | -7865 | -4595 | -10453 | -6827 | -9999 | 1677 | -926 | -2075 |
| Cash Flow from Financing Activities | 453 | -1035 | -1206 | -1428 | -1428 | 0 | 104 | -395 | -1263 | -1754 | -1754 |
| Net Cash Inflow / Outflow | 1795 | 2512 | 2129 | -1688 | 2594 | 2830 | 2328 | 1328 | 202 | -704 | -3363 |
| Closing Cash & Cash Equivalent | 9779 | 12231 | 14257 | 12933 | 16107 | 18589 | 21451 | 23702 | 7769 | 7717 | 7710 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 17.54 | 106.74 | 17.93 | 15.72 | -1.06 | 11.35 | 13.6 | 39.37 | 38.11 | 42.36 | 55.08 |
| CEPS(Rs) | 17.54 | 106.74 | 17.93 | 15.72 | -1.06 | 11.35 | 13.6 | 39.37 | 38.11 | 42.36 | 55.08 |
| DPS(Rs) | 10 | 11.65 | 13.5 | 6.75 | 0 | 0 | 2.25 | 7.2 | 10 | 10 | 13.25 |
| Book NAV/Share(Rs) | 99.17 | 586.7 | 137.68 | 145.31 | 136.48 | 149.64 | 164.31 | 205.18 | 239.03 | 277.36 | 337.99 |
| Core EBITDA Margin(%) | -8.54 | -1.58 | -3.84 | -5.53 | -15.27 | -13.28 | -11.6 | -7.78 | -12.19 | -8.95 | -5.41 |
| EBIT Margin(%) | 20.42 | 15.57 | 9.37 | 10.39 | -0.62 | 8.09 | 9.97 | 23.24 | 24.04 | 26.05 | 30.47 |
| Pre Tax Margin(%) | 20.42 | 15.57 | 9.37 | 10.39 | -0.62 | 8.09 | 9.97 | 23.24 | 24.04 | 26.05 | 30.47 |
| PAT Margin (%) | 19.72 | 13.71 | 8.23 | 7.21 | -0.42 | 4.98 | 6.03 | 19.2 | 19.84 | 20.24 | 24.31 |
| Cash Profit Margin (%) | 19.72 | 13.71 | 8.23 | 7.21 | -0.42 | 4.98 | 6.03 | 19.2 | 19.84 | 20.24 | 24.31 |
| ROA(%) | 7.13 | 8.09 | 6.04 | 5.02 | -0.39 | 4.32 | 4.2 | 10.83 | 8.73 | 8.52 | 10.69 |
| ROE(%) | 18.24 | 19.72 | 14.19 | 11.11 | -0.75 | 7.94 | 8.66 | 21.31 | 17.16 | 16.41 | 17.9 |
| ROCE(%) | 18.89 | 22.38 | 16.15 | 16.01 | -1.11 | 12.89 | 14.31 | 25.8 | 20.79 | 21.11 | 22.43 |
| Receivable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 20.33 | 15.43 | 0 | 17.58 | 8.37 | 3.4 | 8.66 | 9.91 | 6.58 |
| Price/Book(x) | 0 | 0 | 2.65 | 1.67 | 0.77 | 1.33 | 0.69 | 0.65 | 1.38 | 1.51 | 1.07 |
| Dividend Yield(%) | 0 | 0 | 1.85 | 2.78 | 0 | 0 | 1.98 | 5.38 | 3.03 | 2.38 | 3.65 |
| EV/Net Sales(x) | -0.61 | -0.44 | 1.3 | 0.77 | 0.05 | 0.41 | -0.04 | -0.01 | 0.98 | 1.32 | 0.88 |
| EV/Core EBITDA(x) | -5.64 | -4.54 | 19.73 | 10.74 | -2.95 | 12.75 | -0.46 | -0.04 | 7.05 | 8.65 | 4.73 |
| Net Sales Growth(%) | 12.55 | 75 | 42.67 | 0.13 | 15.95 | -9.85 | -1.07 | -9.06 | -6.31 | 8.92 | 8.26 |
| EBIT Growth(%) | 7.01 | 33.37 | -14.09 | 10.98 | -106.89 | 1281.71 | 21.83 | 112.1 | -3.09 | 18.02 | 26.63 |
| PAT Growth(%) | 4.36 | 21.71 | -14.33 | -12.33 | -106.76 | 1168.12 | 19.82 | 189.46 | -3.21 | 11.16 | 30.01 |
| EPS Growth(%) | 4.36 | 508.53 | -83.2 | -12.33 | -106.76 | 1168.12 | 19.82 | 189.46 | -3.21 | 11.16 | 30.01 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 0.64 | 0.66 | 0.67 | 0.62 | 0.62 | 0.55 | 0.53 | 0.53 | 0.52 | 0.52 | 0.54 |
| Quick Ratio(x) | 0.64 | 0.66 | 0.67 | 0.62 | 0.62 | 0.55 | 0.53 | 0.53 | 0.52 | 0.52 | 0.54 |
| Interest Cover(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 85.78 | 85.78 | 82.4 | 82.4 | 82.4 | 82.4 | 82.4 | 82.4 | 82.4 | 77.4 |
| FII | 0.86 | 1.05 | 1.34 | 1.8 | 1.93 | 2.11 | 2.12 | 2.12 | 2.06 | 2.43 |
| DII | 11.06 | 10.91 | 13.71 | 13.7 | 13.67 | 13.3 | 13.1 | 13.32 | 13.55 | 17.73 |
| Public | 2.29 | 2.25 | 2.55 | 2.1 | 2 | 2.2 | 2.39 | 2.16 | 2 | 2.44 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 150.5 | 150.5 | 144.56 | 144.56 | 144.56 | 144.56 | 144.56 | 144.56 | 144.56 | 135.78 |
| FII | 1.52 | 1.84 | 2.35 | 3.17 | 3.39 | 3.7 | 3.72 | 3.72 | 3.61 | 4.27 |
| DII | 19.4 | 19.15 | 24.06 | 24.03 | 23.99 | 23.33 | 22.98 | 23.37 | 23.77 | 31.1 |
| Public | 4.02 | 3.95 | 4.47 | 3.69 | 3.51 | 3.85 | 4.19 | 3.8 | 3.51 | 4.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +8% | +3% | 0% | +10% |
| Operating Profit CAGR | +33% | +12% | +42% | +16% |
| PAT CAGR | +30% | +12% | +37% | +12% |
| Share Price CAGR | -12% | +13% | +18% | — |
| ROE Average | +18% | +17% | +16% | +14% |
| ROCE Average | +22% | +21% | +21% | +17% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 85.78 | 85.78 | 82.4 | 82.4 | 82.4 | 82.4 | 82.4 | 82.4 | 82.4 | 77.4 |
| FII | 0.86 | 1.05 | 1.34 | 1.8 | 1.93 | 2.11 | 2.12 | 2.12 | 2.06 | 2.43 |
| DII | 11.06 | 10.91 | 13.71 | 13.7 | 13.67 | 13.3 | 13.1 | 13.32 | 13.55 | 17.73 |
| Public | 2.29 | 2.25 | 2.55 | 2.1 | 2 | 2.2 | 2.39 | 2.16 | 2 | 2.44 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 150.5 | 150.5 | 144.56 | 144.56 | 144.56 | 144.56 | 144.56 | 144.56 | 144.56 | 135.78 |
| FII | 1.52 | 1.84 | 2.35 | 3.17 | 3.39 | 3.7 | 3.72 | 3.72 | 3.61 | 4.27 |
| DII | 19.4 | 19.15 | 24.06 | 24.03 | 23.99 | 23.33 | 22.98 | 23.37 | 23.77 | 31.1 |
| Public | 4.02 | 3.95 | 4.47 | 3.69 | 3.51 | 3.85 | 4.19 | 3.8 | 3.51 | 4.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 | 175.44 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.